Dayama, Porferio L.

HRN: 01-39-51  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
CO-AMOXICLAV 625MG (TAB)
08/10/2026
08/17/2026
ORAL
625mg
Every 8hours
Multiple Physical Injuries; Lacerated Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines